Julie Mabalot Luk

Effect of Raltegravir on the Pharmacokinetics of Methadone

J. Wagner, W. Hanley, M. Iwamoto, 2010, Journal of clinical pharmacology.

Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib[S]

R. Krauss, C. Pinto, J. Wagner, 2012, Journal of Lipid Research.

The effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin

W. Kraft, J. Wagner, A. van Hecken, 2011, Platelets.

Pharmacokinetics of Laropiprant, a Selective Prostaglandin D2 Receptor 1 Antagonist, in Patients With Moderate Hepatic Impairment

J. Wagner, K. Lasseter, T. Marbury, 2011, Journal of clinical pharmacology.

Jefferson Digital

Inge, W. Kraft, J. Wagner, 2022 .